Preliminary scientific tests reveal conolidine may inhibit specific ion channels, minimizing neuronal excitability and restricting discomfort alerts. This mechanism is especially relevant in neuropathic discomfort, in which abnormal signaling brings about persistent pain. Furthermore, conolidine seems to impact G protein-coupled receptor (GPCR) pathways integral to suffering perceptio... https://johnj273xoe9.wikiap.com/user